Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease

The Lancet

Volumn 390, Issue 10098, 2017, Pages 988-1002

  Maddocks, Matthew ^a   Lovell, Natasha ^a   Booth, Sara ^b,c   Man, William D C ^d   Higginson, Irene J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COCHRANE LIBRARY; COUGHING; DYSPNEA; EMBASE; FATIGUE; HEALTH CARE PLANNING; HUMAN; INTERPERSONAL COMMUNICATION; MEDLINE; PAIN; PALLIATIVE THERAPY; PATIENT REFERRAL; PRIORITY JOURNAL; PULMONARY REHABILITATION; REVIEW; SOCIAL CARE; SURVIVAL; SYSTEMATIC REVIEW; CAREGIVER; DOCTOR PATIENT RELATION; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; SOCIAL SUPPORT; TERMINAL CARE;

CAREGIVERS; DYSPNEA; HUMANS; PALLIATIVE CARE; PHYSICIAN-PATIENT RELATIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SOCIAL SUPPORT; TERMINAL CARE;

EID: 85033390633     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)32127-X     Document Type: Review

References (167)

1. Lozano, R, Naghavi, M, Foreman, K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2095–2128.
2. Murray, CJL, Barber, RM, Foreman, KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386 (2015), 2145–2191.
3. Khakban, A, Sin, DD, FitzGerald, JM, et al. The projected epidemic of COPD hospitalizations over the next 15 years: a population based perspective. Am J Respir Crit Care Med 195 (2017), 287–291.
4. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/, 2016 (accessed April 26, 2017).
5. Calverley, PM, Anderson, JA, Celli, B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 (2007), 775–789.
6. Laveneziana, P, Palange, P, Physical activity, nutritional status and systemic inflammation in COPD. Eur Respir J 40 (2012), 522–529.
7. Vanfleteren, LE, Spruit, MA, Wouters, EF, Franssen, FM, Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med 4 (2016), 911–924.
8. Yin, HL, Yin, SQ, Lin, QY, Xu, Y, Xu, HW, Liu, T, Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis. Medicine, 96, 2017, e6836.
9. Han, MK, Martinez, CH, Au, DH, et al. Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. Lancet Respir Med 4 (2016), 473–526.
10. Seymour, J, Spruit, M, Hopkinson, N, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 36 (2010), 81–88.
11. Zimmermann, C, Swami, N, Krzyzanowska, M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383 (2014), 1721–1730.
12. Kavalieratos, D, Corbelli, J, Zhang, D, et al. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA 316 (2016), 2104–2114.
13. Claessens, MT, Lynn, J, Zhong, Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treatments. J Am Geriatr Soc 48:suppl 5 (2000), S146–S153.
14. Lunney, JR, Lynn, J, Foley, DJ, Lipson, S, Guralnik, JM, Patterns of functional decline at the end of life. JAMA 289 (2003), 2387–2392.
15. Wildman, MJ, Sanderson, C, Groves, J, et al. Implications of prognostic pessimism in patients with chronic obstructive pulmonary disease (COPD) or asthma admitted to intensive care in the UK within the COPD and asthma outcome study (CAOS): multicentre observational cohort study. BMJ, 335, 2007, 1132.
16. Wildman, MJ, Sanderson, C, Groves, J, et al. Predicting mortality for patients with exacerbations of COPD and Asthma in the COPD and Asthma Outcome Study (CAOS). QJM 102 (2009), 389–399.
17. Celli, BR, Cote, CG, Marin, JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004), 1005–1012.
18. Puhan, MA, Garcia-Aymerich, J, Frey, M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 374 (2009), 704–711.
19. Beernaert, K, Cohen, J, Deliens, L, et al. Referral to palliative care in COPD and other chronic diseases: a population-based study. Respir Med 107 (2013), 1731–1739.
20. Rush, B, Hertz, P, Bond, A, McDermid, RC, Celi, LA, Use of palliative care in patients with end-stage copd and receiving home oxygen: national trends and barriers to care in the United States. Chest 151 (2017), 41–46.
21. Singer, AE, Meeker, D, Teno, JM, Lynn, J, Lunney, JR, Lorenz, KA, Symptom trends in the last year of life from 1998 to 2010: a cohort study. Ann Intern Med 162 (2015), 175–183.
22. Teno, JM, Freedman, VA, Kasper, JD, Gozalo, P, Mor, V, Is care for the dying improving in the United States?. J Palliat Med 18 (2015), 662–666.
23. Wachterman, MW, Pilver, C, Smith, D, Ersek, M, Lipsitz, SR, Keating, NL, Quality of end-of-life care provided to patients with different serious illnesses. JAMA Intern Med 176 (2016), 1095–1102.
24. Cohen, J, Beernaert, K, Van den Block, L, et al. Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data. NPJ Prim Care Respir Med, 27, 2017, 14.
25. Gomes, B, Calanzani, N, Gysels, M, Hall, S, Higginson, IJ, Heterogeneity and changes in preferences for dying at home: a systematic review. BMC Palliat Care, 12, 2013, 7.
26. Higginson, IJ, Reilly, CC, Bajwah, S, Maddocks, M, Costantini, M, Gao, W, Which patients with advanced respiratory disease die in hospital? A 14-year population-based study of trends and associated factors. BMC Med, 15, 2017, 19.
27. Disler, RT, Green, A, Luckett, T, et al. Experience of advanced chronic obstructive pulmonary disease: metasynthesis of qualitative research. J Pain Symptom Manage 48 (2014), 1182–1199.
28. Pinnock, H, Kendall, M, Murray, SA, et al. Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ Support Palliat Care 1 (2011), 174–183.
29. Edmonds, P, Karlsen, S, Khan, S, Addington-Hall, J, A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 15 (2001), 287–295.
30. Blinderman, CD, Homel, P, Billings, JA, Tennstedt, S, Portenoy, RK, Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage 38 (2009), 115–123.
31. Bausewein, C, Booth, S, Gysels, M, Kuhnbach, R, Haberland, B, Higginson, IJ, Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med 13 (2010), 1109–1118.
32. Wysham, NG, Cox, CE, Wolf, SP, Kamal, AH, Symptom burden of chronic lung disease compared with lung cancer at time of referral for palliative care consultation. Ann Am Thorac Soc 12 (2015), 1294–1301.
33. Moens, K, Higginson, IJ, Harding, R, Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. J Pain Symptom Manage 48 (2014), 660–677.
34. Divo, M, Cote, C, de Torres, JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186 (2012), 155–161.
35. Barnett, K, Mercer, SW, Norbury, M, Watt, G, Wyke, S, Guthrie, B, Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380 (2012), 37–43.
36. Kendall, M, Carduff, E, Lloyd, A, et al. Different experiences and goals in different advanced diseases: comparing serial interviews with patients with cancer, organ failure, or frailty and their family and professional carers. J Pain Symptom Manage 50 (2015), 216–224.
37. Giacomini, M, DeJean, D, Simeonov, D, Smith, A, Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature. Ont Health Technol Assess Ser 12 (2012), 1–47.
38. Hanania, NA, Mullerova, H, Locantore, NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 183 (2011), 604–611.
39. Willgoss, TG, Yohannes, AM, Anxiety disorders in patients with COPD: a systematic review. Respir Care 58 (2013), 858–866.
40. Gysels, M, Higginson, IJ, Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness. J Pain Symptom Manage 36 (2008), 451–460.
41. Gysels, M, Bausewein, C, Higginson, IJ, Experiences of breathlessness: a systematic review of the qualitative literature. Palliat Support Care 5 (2007), 281–302.
42. Solomon, BK, Wilson, KG, Henderson, PR, Poulin, PA, Kowal, J, McKim, DA, Loss of dignity in severe chronic obstructive pulmonary disease. J Pain Symptom Manage 51 (2016), 529–537.
43. Chochinov, HM, Johnston, W, McClement, SE, et al. Dignity and distress towards the end of life across four non-cancer populations. PloS One, 11, 2016, e0147607.
44. Chochinov, HM, Hack, T, Hassard, T, Kristjanson, LJ, McClement, S, Harlos, M, Dignity in the terminally ill: a cross-sectional, cohort study. Lancet 360 (2002), 2026–2030.
45. McCarthy, B, Casey, D, Devane, D, Murphy, K, Murphy, E, Lacasse, Y, Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2, 2015 Cd003793.
46. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1 (1981), 681–686.
47. Albert, RK, Au, DH, Blackford, AL, et al. A randomized trial of long-term oxygen for copd with moderate desaturation. N Engl J Med 375 (2016), 1617–1627.
48. Murphy, PB, Rehal, S, Arbane, G, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute copd exacerbation: a randomized clinical trial. JAMA 317 (2017), 2177–2186.
49. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume–reduction surgery with medical therapy for severe emphysema. N Engl J Med 348 (2003), 2059–2073.
50. Lanken, PN, Terry, PB, Delisser, HM, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 177 (2008), 912–927.
51. Meharry, R, Anderson, D, Assessing symptom burden in patients with advanced COPD—is CAT enough?. Europ Resp J, 48(suppl 60), 2016, PA3731 (abstr).
52. Hearn, J, Higginson, IJ, Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Qual Health Care 8 (1999), 219–227.
53. Müllerová, H, Lu, C, Li, H, Tabberer, M, Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One, 9, 2014, e85540.
54. Puhan, MA, Gimeno-Santos, E, Cates, CJ, Troosters, T, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 12, 2016 Cd005305.
55. Higginson, IJ, Bausewein, C, Reilly, CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med 2 (2014), 979–987.
56. Farquhar, MC, Prevost, AT, McCrone, P, et al. The clinical and cost effectiveness of a Breathlessness Intervention Service for patients with advanced non-malignant disease and their informal carers: mixed findings of a mixed method randomised controlled trial. Trials, 17, 2016, 185.
57. Holland, AE, Hill, CJ, Jones, AY, McDonald, CF, Breathing exercises for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 10, 2012 Cd008250.
58. Galbraith, S, Fagan, P, Perkins, P, Lynch, A, Booth, S, Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 39 (2010), 831–838.
59. Booth, S, Farquhar, M, Gysels, M, Bausewein, C, Higginson, IJ, The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study. Palliat Support Care 4 (2006), 287–293.
60. Howard, C, Dupont, S, ‘The COPD breathlessness manual’: a randomised controlled trial to test a cognitive-behavioural manual versus information booklets on health service use, mood and health status, in patients with chronic obstructive pulmonary disease. NPJ Prim Care Respir Med, 24, 2014, 14076.
61. Ngai, SP, Jones, AY, Tam, WW, Tai Chi for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev, 6, 2016 Cd009953.
62. Donesky-Cuenco, D, Nguyen, HQ, Paul, S, Carrieri-Kohlman, V, Yoga therapy decreases dyspnea-related distress and improves functional performance in people with chronic obstructive pulmonary disease: a pilot study. J Altern Complement Med 15 (2009), 225–234.
63. Barnes, H, McDonald, J, Smallwood, N, Manser, R, Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev, 3, 2016 Cd011008.
64. Ekstrom, M, Bajwah, S, Bland, JM, Currow, DC, Hussain, J, Johnson, MJ, One evidence base; three stories: do opioids relieve chronic breathlessness?. Thorax, 2017 published online April 4. DOI:10.1136/thoraxjnl-2016-209868.
65. Simon, ST, Higginson, IJ, Booth, S, Harding, R, Weingartner, V, Bausewein, C, Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev, 10, 2016 Cd007354.
66. Abernethy, AP, McDonald, CF, Frith, PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 376 (2010), 784–793.
67. Baltzan, MA, Scott, AS, Wolkove, N, et al. Fatigue in COPD: prevalence and effect on outcomes in pulmonary rehabilitation. Chron Respir Dis 8 (2011), 119–128.
68. Lewko, A, Bidgood, P, Jewell, A, Garrod, R, A comprehensive literature review of COPD-related fatigue. Curr Respir Med Rev 8 (2012), 370–382.
69. Rea, H, McAuley, S, Stewart, A, Lamont, C, Roseman, P, Didsbury, P, A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J 34 (2004), 608–614.
70. Slater, G, Steier, J, Excessive daytime sleepiness in sleep disorders. J Thorac Dis 4 (2012), 608–616.
71. Ferreira, IM, Brooks, D, White, J, Goldstein, R, Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 12, 2012 CD000998.
72. Weisberg, J, Wanger, J, Olson, J, et al. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest 121 (2002), 1070–1078.
73. van Dam van Isselt, EF, Groenewegen-Sipkema, KH, Spruit-van Eijk, M, et al. Pain in patients with COPD: a systematic review and meta-analysis. BMJ Open, 4, 2014, e005898.
74. Mikkelsen, RL, Middelboe, T, Pisinger, C, Stage, KB, Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 58 (2004), 65–70.
75. Coventry, PA, Bower, P, Keyworth, C, et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One, 8, 2013, e60532.
76. Rayner, L, Price, A, Evans, A, Valsraj, K, Higginson, IJ, Hotopf, M, Antidepressants for depression in physically ill people. Cochrane Database Syst Rev, 3, 2010 Cd007503.
77. Smith, SM, Sonego, S, Ketcheson, L, Larson, JL, A review of the effectiveness of psychological interventions used for anxiety and depression in chronic obstructive pulmonary disease. BMJ Open Respir Res, 1, 2014, e000042.
78. Usmani, ZA, Carson, KV, Heslop, K, Esterman, AJ, De Soyza, A, Smith, BJ, Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 3, 2017 CD010673.
79. Usmani, ZA, Carson, KV, Cheng, JN, Esterman, AJ, Smith, BJ, Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 11, 2011 CD008483.
80. Rennard, S, Decramer, M, Calverley, PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 20 (2002), 799–805.
81. Chamberlain Mitchell, SA, Garrod, R, Clark, L, et al. Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial. Thorax 72 (2017), 129–136.
82. Vertigan, AE, Kapela, SL, Ryan, NM, Birring, SS, McElduff, P, Gibson, PG, Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial. Chest 149 (2016), 639–648.
83. Ryan, NM, Birring, SS, Gibson, PG, Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 380 (2012), 1583–1589.
84. Budhiraja, R, Parthasarathy, S, Budhiraja, P, Habib, MP, Wendel, C, Quan, SF, Insomnia in patients with COPD. Sleep 35 (2012), 369–375.
85. Struik, FM, Lacasse, Y, Goldstein, R, Kerstjens, HM, Wijkstra, PJ, Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 6, 2013 CD002878.
86. Trauer, JM, Qian, MY, Doyle, JS, Rajaratnam, SM, Cunnington, D, Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med 163 (2015), 191–204.
87. Lu, XM, Zhu, JP, Zhou, XM, The effect of benzodiazepines on insomnia in patients with chronic obstructive pulmonary disease: a meta-analysis of treatment efficacy and safety. Int J Chron Obstruct Pulmon Dis 11 (2016), 675–685.
88. Norden, J, Gronberg, AM, Bosaeus, I, et al. Nutrition impact symptoms and body composition in patients with COPD. Eur J Clin Nutr 69 (2015), 256–261.
89. Furness, S, Worthington, HV, Bryan, G, Birchenough, S, McMillan, R, Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev, 12, 2011 CD008934.
90. Kahraman, H, Sen, B, Koksal, N, Kilinç, M, Resim, S, Erectile dysfunction and sex hormone changes in chronic obstructive pulmonary disease patients. Multidiscip Respir Med, 8, 2013, 66.
91. Levack, WM, Sexual wellbeing for people with chronic obstructive pulmonary disease: relevance and roles for physiotherapy. N Z J Physio 42 (2013), 170–176.
92. Levack, WMM, Poot, B, Weatherall, M, Travers, J, Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev, 9, 2015 CD011442.
93. Cherny, N, Fallon, M, Kaasa, S, Portenoy, R, Currow, D, Oxford textbook of palliative medicine, 2015, Oxford University Press, Oxford.
94. Twycross, R, Wilcock, A, Howard, P, Palliative care formulary. Palliativedrugs.com, 2014 5th edn. Nottingham, UK:.
95. Yorke, J, Lloyd-Williams, M, Smith, J, et al. Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial. Support Care Cancer 23 (2015), 3373–3384.
96. Simon, ST, Weingartner, V, Higginson, IJ, et al. “I can breathe again!” Patients' self-management strategies for episodic breathlessness in advanced disease, derived from qualitative interviews. J Pain Symptom Manage 52 (2016), 228–234.
97. Chin, C, Booth, S, Managing breathlessness: a palliative care approach. Postgrad Med J 92 (2016), 393–400.
98. Spathis, A, Booth, S, Moffat, C, et al. The Breathing, Thinking, Functioning clinical model: a proposal to facilitate evidence-based breathlessness management in chronic respiratory disease. NPJ Prim Care Respir Med, 27, 2017, 27.
99. Currow, DC, McDonald, C, Oaten, S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage 42 (2011), 388–399.
100. Spruit, MA, Vercoulen, JH, Sprangers, MAG, Wouters, EFM, Fatigue in COPD: an important yet ignored symptom. Lancet Respir Med 5 (2017), 542–544.
101. Payne, C, Wiffen, PJ, Martin, S, Interventions for fatigue and weight loss in adults with advanced progressive illness. Cochrane Database Syst Rev, 1, 2012 CD008427.
102. Breslin, E, van der Schans, C, Breukink, S, et al. Perception of fatigue and quality of life in patients with COPD. Chest 114 (1998), 958–964.
103. Habraken, JM, Pols, J, Bindels, PJ, Willems, DL, The silence of patients with end-stage COPD: a qualitative study. Br J Gen Pract 58 (2008), 844–849.
104. Mucke, M, Cuhls, H, Peuckmann-Post, V, Minton, O, Stone, P, Radbruch, L, Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev, 5, 2015 Cd006788.
105. McGarvey, L, Morice, AH, Smith, JA, et al. Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials. BMJ Open Respir Res, 3, 2016, e000148.
106. Birring, SS, Floyd, S, Reilly, CC, Cho, PSP, Physiotherapy and speech and language therapy intervention for chronic cough. Pulm Pharmacol Ther, 2017 published online April 4. DOI:10.1016/j.pupt.2017.04.001.
107. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet; 380: 1583–89.
108. Abdulqawi, R, Dockry, R, Holt, K, et al. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet 385 (2015), 1198–1205.
109. HajGhanbari, B, Holsti, L, Road, JD, Darlene Reid, W, Pain in people with chronic obstructive pulmonary disease (COPD). Respir Med 106 (2012), 998–1005.
110. Guidelines and audit implementation network (GAIN). General palliative care guidelines for the management of pain at end of life in adult patients, 2011, GAIN, Belfast.
111. Dowell, D, Haegerich, TM, Chou, R, CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep 315 (2016), 1–49.
112. Noble, M, Treadwell, JR, Tregear, SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev, 1, 2010 Cd006605.
113. Vozoris, NT, Wang, X, Fischer, HD, et al. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J 48 (2016), 683–693.
114. Ahmadi, Z, Bernelid, E, Currow, DC, Ekstrom, M, Prescription of opioids for breathlessness in end-stage COPD: a national population-based study. Int J Chron Obstruct Pulmon Dis 11 (2016), 2651–2657.
115. Sullivan, MD, Von Korff, M, Banta-Green, C, Merrill, JO, Saunders, K, Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain 149 (2010), 345–353.
116. The Lancet. Complexities of care in COPD. Lancet, 389, 2017, 574.
117. Steinhauser, KE, Christakis, NA, Clipp, EC, McNeilly, M, McIntyre, L, Tulsky, JA, Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 284 (2000), 2476–2482.
118. Singer, PA, Martin, DK, Kelner, M, Quality end-of-life care: patients' perspectives. JAMA 281 (1999), 163–168.
119. Kunik, ME, Veazey, C, Cully, JA, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med 38 (2008), 385–396.
120. Gysels, MH, Higginson, IJ, Self-management for breathlessness in COPD: the role of pulmonary rehabilitation. Chron Respir Dis 6 (2009), 133–140.
121. Pilling, S, Anderson, I, Goldberg, D, Meader, N, Taylor, C, On behalf of the two guideline development g. Depression in adults, including those with a chronic physical health problem: summary of NICE guidance. BMJ, 339, 2009, b4108.
122. Chochinov, HM, Kristjanson, LJ, Breitbart, W, et al. Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial. Lancet Oncol 12 (2011), 753–762.
123. Martínez, M, Arantzamendi, M, Belar, A, et al. ‘Dignity therapy’, a promising intervention in palliative care: A comprehensive systematic literature review. Pall Med 31 (2017), 492–509.
124. Tawakol, A, Ishai, A, Takx, RA, et al. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet 389 (2017), 834–845.
125. Benzo, RP, Kirsch, JL, Dulohery, MM, Abascal-Bolado, B, Emotional intelligence: a novel outcome associated with wellbeing and self-management in chronic obstructive pulmonary disease. Ann Am Thorac Soc 13 (2016), 10–16.
126. Nakken, N, Janssen, DJ, van den Bogaart, EH, et al. Informal caregivers of patients with COPD: home sweet home?. Eur Respir Rev 24 (2015), 498–504.
127. Farquhar, M, Supporting informal carers. Bausewein, C, Currow, DC, Johnson, MJ, (eds.) Palliative care in respiratory disease, 2016, European Respiratory Society, Lausanne.
128. Farquhar, M, Carers and breathlessness. Curr Opin Support Palliat Care, 2017 published online June 14. DOI:10.1097/SPC.0000000000000281.
129. Farquhar, M, Penfold, C, Benson, J, et al. Six key topics informal carers of patients with breathlessness in advanced disease want to learn about and why: MRC phase I study to inform an educational intervention. PloS One, 12, 2017, e0177081.
130. Janssen, DJ, Spruit, MA, Wouters, EF, Schols, JM, Family caregiving in advanced chronic organ failure. J Am Med Dir Assoc 13 (2012), 394–399.
131. Curtis, JR, Engelberg, RA, Nielsen, EL, Au, DH, Patrick, DL, Patient-physician communication about end-of-life care for patients with severe COPD. Eur Respir J 24 (2004), 200–205.
132. Janssen, DJ, Spruit, MA, Schols, JM, Wouters, EF, A call for high-quality advance care planning in outpatients with severe COPD or chronic heart failure. Chest 139 (2011), 1081–1088.
133. Knauft, E, Nielsen, EL, Engelberg, RA, Patrick, DL, Curtis, JR, Barriers and facilitators to end-of-life care communication for patients with COPD. Chest 127 (2005), 2188–2196.
134. Gott, M, Gardiner, C, Small, N, et al. Barriers to advance care planning in chronic obstructive pulmonary disease. Palliat Med 23 (2009), 642–648.
135. Janssen, DJ, Engelberg, RA, Wouters, EF, Curtis, JR, Advance care planning for patients with COPD: past, present and future. Patient Educ Couns 86 (2012), 19–24.
136. Patel, K, Janssen, DJ, Curtis, JR, Advance care planning in COPD. Respirology (Carlton, Vic) 17 (2012), 72–78.
137. Wright, AA, Zhang, B, Ray, A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300 (2008), 1665–1673.
138. Bernacki, RE, Block, SD, Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med 174 (2014), 1994–2003.
139. Brighton, LJ, Bristowe, K, Communication in palliative care: talking about the end of life, before the end of life. Postgrad Med J 92 (2016), 466–470.
140. Momen, N, Hadfield, P, Kuhn, I, Smith, E, Barclay, S, Discussing an uncertain future: end-of-life care conversations in chronic obstructive pulmonary disease. A systematic literature review and narrative synthesis. Thorax 67 (2012), 777–780.
141. Curtis, JR, Engelberg, R, Young, JP, et al. An approach to understanding the interaction of hope and desire for explicit prognostic information among individuals with severe chronic obstructive pulmonary disease or advanced cancer. J Palliat Med 11 (2008), 610–620.
142. Back, AL, Arnold, RM, Discussing prognosis: “How much do you want to know?” Talking to patients who are prepared for explicit information. J Clin Oncol 24 (2006), 4209–4213.
143. Houben, CHM, Spruit, MA, Schols, JMA, Wouters, EFM, Janssen, DJA, Instability of willingness to accept life-sustaining treatments of patients with advanced chronic organ failure during one year. Chest 151 (2016), 1081–1087.
144. Andreassen, P, Neergaard, MA, Brogaard, T, Skorstengaard, MH, Jensen, AB, The diverse impact of advance care planning: a long-term follow-up study on patients' and relatives' experiences. BMJ Support Palliat Care, 2015 published online Sept 30. DOI:10.1136/bmjspcare-2015-000886.
145. Houben, CH, Spruit, MA, Groenen, MT, Wouters, EF, Janssen, DJ, Efficacy of advance care planning: a systematic review and meta-analysis. J Am Med Dir Assoc 15 (2014), 477–489.
146. Au, DH, Udris, EM, Engelberg, RA, et al. A randomized trial to improve communication about end-of-life care among patients with COPD. Chest 141 (2012), 726–735.
147. Jacobsen, J, Jackson, V, Dahlin, C, et al. Components of early outpatient palliative care consultation in patients with metastatic nonsmall cell lung cancer. J Palliat Med 14 (2011), 459–464.
148. Yoong, J, Park, ER, Greer, JA, et al. Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med 173 (2013), 283–290.
149. Coventry, PA, Grande, GE, Richards, DA, Todd, CJ, Prediction of appropriate timing of palliative care for older adults with non-malignant life-threatening disease: a systematic review. Age Ageing 34 (2005), 218–227.
150. Philip, J, Crawford, G, Brand, C, et al. A conceptual model: redesigning how we provide palliative care for patients with chronic obstructive pulmonary disease. Palliat Support Care, 2017 published online May 31. DOI:10.1017/S147895151700044X.
151. Gysels, M, Reilly, CC, Jolley, CJ, et al. How does a new breathlessness support service affect patients?. Eur Respir J 46 (2015), 1515–1518.
152. Hui, D, Bruera, E, Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol 13 (2016), 159–171.
153. Hui, D, Kim, YJ, Park, JC, et al. Integration of oncology and palliative care: a systematic review. Oncologist 20 (2015), 77–83.
154. Hui, D, Bruera, E, Models of integration of oncology and palliative care. Ann Palliat Med 4 (2015), 89–98.
155. Buckingham, S, Kendall, M, Ferguson, S, et al. HELPing older people with very severe chronic obstructive pulmonary disease (HELP-COPD): mixed-method feasibility pilot randomised controlled trial of a novel intervention. NPJ Prim Care Respir Med, 25, 2015, 15020.
156. Ospina, MB, Mrklas, K, Deuchar, L, et al. A systematic review of the effectiveness of discharge care bundles for patients with COPD. Thorax 72 (2017), 31–39.
157. Rocker, GM, Cook, D, ‘INSPIRED’ approaches to better care for patients with advanced COPD. Clin Invest Med 36 (2013), E114–E120.
158. Verma, JY, Amar, C, Sibbald, S, Rocker, GM, Improving care for advanced COPD through practice change: experiences of participation in a Canadian spread collaborative. Chron Respir Dis, 2017 published online Jan 1. DOI:10.1177/1479972317712720.
159. Steiner, MC, Evans, RA, Greening, NJ, et al. Comprehensive respiratory assessment in advanced COPD: a ‘campus to clinic’ translational framework. Thorax 70 (2015), 805–808.
160. Heffner, JE, Fahy, B, Hilling, L, Barbieri, C, Attitudes regarding advance directives among patients in pulmonary rehabilitation. Am J Respir Crit Care Med 154 (1996), 1735–1740.
161. Harrington, SE, Rogers, E, Davis, M, Palliative care and chronic obstructive pulmonary disease: where the lines meet. Curr Opin Pulm Med 23 (2017), 154–160.
162. Steiner, MC, Lowe, D, Beckford, K, et al. Socioeconomic deprivation and the outcome of pulmonary rehabilitation in England and Wales. Thorax 72 (2017), 530–537.
163. Maddocks, M, Kon, SS, Canavan, JL, et al. Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study. Thorax 71 (2016), 988–995.
164. Jones, S, Man, WD, Gao, W, Higginson, IJ, Wilcock, A, Maddocks, M, Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database Syst Rev, 10, 2016 Cd009419.
165. Maddocks, M, Nolan, CM, Man, WD, et al. Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: a randomised double-blind, placebo-controlled trial. Lancet Respir Med 4 (2016), 27–36.
166. Griffiths, TL, Burr, ML, Campbell, IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 355 (2000), 362–368.
167. Ali Zohal, M, Yazdi, Z, Kazemifar, AM, Daytime sleepiness and quality of sleep in patients with COPD compared to control group. Global J Health Sci 5 (2013), 150–155.